CBIZ Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
CBIZ wird ein jährliches Gewinn- und Umsatzwachstum von 17.7% bzw. 4.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 17.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 17.4% betragen.
Wichtige Informationen
17.7%
Wachstumsrate der Gewinne
17.5%
EPS-Wachstumsrate
Professional Services Gewinnwachstum | 15.5% |
Wachstumsrate der Einnahmen | 4.2% |
Zukünftige Eigenkapitalrendite | 17.4% |
Analystenabdeckung | Low |
Zuletzt aktualisiert | 01 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
CBIZ, Inc. Just Missed EPS By 43%: Here's What Analysts Think Will Happen Next
Aug 02CBIZ, Inc. (NYSE:CBZ) Analysts Are Pretty Bullish On The Stock After Recent Results
Apr 28Recent updates
Is CBIZ, Inc. (NYSE:CBZ) Trading At A 44% Discount?
Oct 18Should You Investigate CBIZ, Inc. (NYSE:CBZ) At US$72.73?
Sep 05Slowing Rates Of Return At CBIZ (NYSE:CBZ) Leave Little Room For Excitement
Aug 20CBIZ: A Big Deal, Deviating From Its Bolt-On Acquisition Strategy
Aug 06CBIZ, Inc. Just Missed EPS By 43%: Here's What Analysts Think Will Happen Next
Aug 02CBIZ, Inc.'s (NYSE:CBZ) Shareholders Might Be Looking For Exit
Jun 24Calculating The Intrinsic Value Of CBIZ, Inc. (NYSE:CBZ)
Jun 06Should You Investigate CBIZ, Inc. (NYSE:CBZ) At US$78.72?
May 21We Take A Look At Whether CBIZ, Inc.'s (NYSE:CBZ) CEO May Be Underpaid
May 03CBIZ, Inc. (NYSE:CBZ) Analysts Are Pretty Bullish On The Stock After Recent Results
Apr 28CBIZ, Inc.'s (NYSE:CBZ) Shares May Have Run Too Fast Too Soon
Mar 25Slowing Rates Of Return At CBIZ (NYSE:CBZ) Leave Little Room For Excitement
Feb 19CBIZ: A Recent Gap-Up May Not Mark The End Of Its Profitable Growth
Feb 19Should You Investigate CBIZ, Inc. (NYSE:CBZ) At US$63.95?
Feb 06If EPS Growth Is Important To You, CBIZ (NYSE:CBZ) Presents An Opportunity
Jan 23CBIZ, Inc.'s (NYSE:CBZ) Price Is Out Of Tune With Earnings
Dec 20Are Investors Undervaluing CBIZ, Inc. (NYSE:CBZ) By 42%?
Nov 01CBIZ: High-Performing Consulting Company With Further Room To Grow
Oct 14Here's Why We Think CBIZ (NYSE:CBZ) Might Deserve Your Attention Today
Oct 10CBIZ Stock Still Looks Fairly Valued (Rating Downgrade)
Sep 28The Returns At CBIZ (NYSE:CBZ) Aren't Growing
Sep 22CBIZ, Inc. (NYSE:CBZ) Shares Could Be 36% Below Their Intrinsic Value Estimate
Jul 20Does CBIZ (NYSE:CBZ) Deserve A Spot On Your Watchlist?
Jun 27The Return Trends At CBIZ (NYSE:CBZ) Look Promising
Jun 05We Ran A Stock Scan For Earnings Growth And CBIZ (NYSE:CBZ) Passed With Ease
Mar 10The Return Trends At CBIZ (NYSE:CBZ) Look Promising
Feb 20CBIZ Non-GAAP EPS of -$0.21 in-line, revenue of $295M beats by $13.44M
Feb 16CBIZ: A Fairly Valued Compounder Hiding In Plain Sight
Dec 14Is There An Opportunity With CBIZ, Inc.'s (NYSE:CBZ) 37% Undervaluation?
Dec 13Is Now The Time To Put CBIZ (NYSE:CBZ) On Your Watchlist?
Nov 18CBIZ Non-GAAP EPS of $0.51 beats by $0.05, revenue of $363.26M beats by $32.7M
Oct 27Returns On Capital Are Showing Encouraging Signs At CBIZ (NYSE:CBZ)
Oct 06CBIZ, Inc.'s (NYSE:CBZ) Intrinsic Value Is Potentially 65% Above Its Share Price
Aug 22Here's Why We Think CBIZ (NYSE:CBZ) Might Deserve Your Attention Today
Aug 07Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 1,825 | 170 | 192 | 204 | 1 |
12/31/2025 | 1,798 | 153 | 177 | 189 | 3 |
12/31/2024 | 1,706 | 119 | 142 | 154 | 3 |
9/30/2024 | 1,681 | 119 | 141 | 164 | N/A |
6/30/2024 | 1,652 | 118 | 130 | 148 | N/A |
3/31/2024 | 1,631 | 125 | 110 | 134 | N/A |
12/31/2023 | 1,591 | 121 | 130 | 154 | N/A |
9/30/2023 | 1,559 | 122 | 102 | 123 | N/A |
6/30/2023 | 1,511 | 116 | 111 | 127 | N/A |
3/31/2023 | 1,475 | 120 | 121 | 133 | N/A |
12/31/2022 | 1,412 | 105 | 117 | 126 | N/A |
9/30/2022 | 1,360 | 107 | 102 | 110 | N/A |
6/30/2022 | 1,279 | 101 | 84 | 93 | N/A |
3/31/2022 | 1,196 | 79 | 86 | 95 | N/A |
12/31/2021 | 1,105 | 71 | 122 | 131 | N/A |
9/30/2021 | 1,073 | 80 | 137 | 146 | N/A |
6/30/2021 | 1,029 | 79 | 148 | 158 | N/A |
3/31/2021 | 987 | 92 | 141 | 151 | N/A |
12/31/2020 | 964 | 78 | 135 | 147 | N/A |
9/30/2020 | 956 | 77 | 117 | 131 | N/A |
6/30/2020 | 957 | 75 | 122 | 134 | N/A |
3/31/2020 | 956 | 70 | 93 | 104 | N/A |
12/31/2019 | 948 | 71 | 84 | 98 | N/A |
9/30/2019 | 944 | 71 | 76 | 91 | N/A |
6/30/2019 | 929 | 67 | 68 | 84 | N/A |
3/31/2019 | 926 | 63 | 84 | 101 | N/A |
12/31/2018 | 922 | 62 | 91 | 105 | N/A |
9/30/2018 | 918 | 67 | 90 | 102 | N/A |
6/30/2018 | 902 | 64 | N/A | 94 | N/A |
3/31/2018 | 880 | 62 | N/A | 71 | N/A |
12/31/2017 | 855 | 51 | N/A | 77 | N/A |
9/30/2017 | 839 | 46 | N/A | 74 | N/A |
6/30/2017 | 831 | 47 | N/A | 73 | N/A |
3/31/2017 | 817 | 44 | N/A | 74 | N/A |
12/31/2016 | 800 | 41 | N/A | 74 | N/A |
9/30/2016 | 785 | 40 | N/A | 57 | N/A |
6/30/2016 | 773 | 39 | N/A | 65 | N/A |
3/31/2016 | 761 | 37 | N/A | 55 | N/A |
12/31/2015 | 750 | 35 | N/A | 47 | N/A |
9/30/2015 | 743 | 34 | N/A | 47 | N/A |
6/30/2015 | 736 | 32 | N/A | 43 | N/A |
3/31/2015 | 729 | 32 | N/A | 41 | N/A |
12/31/2014 | 719 | 30 | N/A | 44 | N/A |
9/30/2014 | 697 | 29 | N/A | 11 | N/A |
6/30/2014 | 686 | 27 | N/A | -10 | N/A |
3/31/2014 | 681 | 26 | N/A | -11 | N/A |
12/31/2013 | 677 | 25 | N/A | -2 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: CBZDas prognostizierte Gewinnwachstum (17.7% pro Jahr) liegt über der Sparquote (2.5%).
Ertrag vs. Markt: CBZDie Erträge des Unternehmens (17.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (15.4% pro Jahr).
Hohe Wachstumserträge: CBZDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: CBZDie Einnahmen des Unternehmens (4.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.9% pro Jahr).
Hohe Wachstumseinnahmen: CBZDie Einnahmen des Unternehmens (4.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: CBZDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (17.4%).